Beauty Health CO

SkinHealth Systems Inc. announced the results of its annual meeting of stockholders held on June 10, 2026, including the election of nine directors and the ratification of its independent auditor.

SkinHealth Systems Inc. files an amendment to its Form 8-K to disclose the details of a severance agreement with former Chief Revenue Officer, Ronald Menezes.

SkinHealth Systems Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, with 180 days to regain compliance.

SkinHealth Systems Inc. announced the termination of Chief Revenue Officer Ronald Menezes without cause, effective May 5, 2026, with separation agreement details pending.

The Beauty Health Company announced its corporate rebrand to SkinHealth Systems Inc., effective immediately, signaling a strategic shift towards a clinically driven, science-backed medical aesthetics platform, alongside the appointment of three new independent directors to its Board.

BeautyHealth reported improved margins and profitability in the fourth quarter and full year 2025, despite a decrease in overall net sales.

SkinHealth Systems reports a net loss of $6.6 million for Q1 2026 as the company navigates macroeconomic headwinds and ongoing legal proceedings.

The Beauty Health Company reported a net loss of $11.0 million in Q3 2025, alongside a significant debt exchange and ongoing legal challenges.

The Beauty Health Company reported a net income of $19.7 million in Q2 2025, driven by a significant debt exchange gain, despite a 13.7% decline in net sales.

The Beauty Health Company reported a 14.5% decrease in first-quarter net sales to $69.6 million year-over-year, primarily due to lower delivery system sales, while consumables revenue grew and gross margin improved as the company restructures its China operations and contends with multiple legal challenges.

The Beauty Health Company's Q3 2024 results show a decrease in revenue, particularly in delivery systems, alongside ongoing legal challenges and inventory adjustments.

The Beauty Health Company experienced a decrease in delivery system sales but saw growth in consumables, alongside a strategic repurchase of convertible notes, impacting their second-quarter financial results.

The Beauty Health Company reported a 10% decrease in net sales for 2025, driven by lower Delivery System sales, while improving gross margin and reducing operating losses amidst strategic debt restructuring and ongoing legal challenges.

The Beauty Health Company's 2024 10-K filing reveals a year of strategic shifts, financial adjustments, and ongoing efforts to maintain its competitive edge in the beauty health industry.

The Beauty Health Company's 2023 10-K filing outlines its financial performance, strategic initiatives, and risk factors, highlighting both challenges and opportunities in the beauty health market.

Sheri Lewis, CSO and COO of Beauty Health Co, reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Michael P. Monahan, Chief Financial Officer of The Beauty Health Company, reported a transaction involving Class A Common Stock.

Pedro Bruno Ferreira Malha, President and CEO of The Beauty Health Company, received a grant of 2,654,867 restricted stock units.

The Beauty Health Company's CFO, Michael P. Monahan, was granted 746,681 Restricted Stock Units, vesting over three years.

The Beauty Health Company's Chief Revenue Officer, Ronald Menezes, was granted 746,681 restricted stock units vesting over three years.

Beauty Health Company's CSO and COO, Sheri Lewis, was granted 746,681 restricted stock units, vesting over three years.

SkinHealth Systems Inc. has issued its 2026 proxy statement, detailing director elections, executive compensation, and ongoing legal proceedings.

The Beauty Health Company's proxy statement details director nominees, executive compensation, corporate governance, and upcoming annual meeting information for stockholders.

The Beauty Health Company's annual meeting of stockholders will be held virtually on June 6, 2024, to vote on key proposals including director elections and amendments to the company's charter.

Linden Capital Partners reports a change in its percentage ownership of SkinHealth Systems Inc. due to an increase in the issuer's outstanding shares.

BlackRock Portfolio Management LLC has reported a beneficial ownership of 5.6% in Skinhealth Systems Inc. Class A Stock as of June 30, 2026.

Capricorn Fund Managers Limited has increased its beneficial ownership of SkinHealth Systems Inc. Ordinary Shares - Class A to 17.2%.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 10,201,685 shares, representing 7.9% of SkinHealth Systems Inc.'s Class A Common Stock as of June 30, 2026.

FMR LLC, through its subsidiaries, has reported beneficial ownership of 17,183,231 shares, representing 13.4% of the Class A Common Stock of Beauty Health Co. as of March 31, 2026.

Millennium Management LLC and affiliated entities have reported a 5.1% beneficial ownership stake in The Beauty Health Company.

Mirabella Financial Services LLP has filed an amendment to its Schedule 13G, reporting a complete divestment of its beneficial ownership in Beauty Health Company.